Article
No KRAS mutations found in gastrointestinal stromal tumors (GISTs): molecular genetic study of 514 cases.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Nov 2013
Lasota Jerzy, Xi Liqiang, Coates Tiffany, Dennis RaShonda, Evbuomwan Moses O, Wang Zeng-Feng, Raffeld Mark, Miettinen Markku
Abstract excerpt
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. A great majority of GISTs is driven by pathological activation of KIT or platelet-derived growth factor receptor-α (PDGFRA), two closely related receptor tyrosine kinases. However, other genetic changes including gain-of-function BRAF mutations and loss of succinate dehydrogenase (SDH) complex activity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
